![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1383499
ÀÇ·á¿ë ·Îº¿ ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çü, Á¦Ç°, ¼³Á¤, À¯Åë ä³Î, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®Medical Robotics Market Forecasts to 2030 - Global Analysis By Type, Product, Setting, Distribution channel, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°è ÀÇ·á¿ë ·Îº¿ ½ÃÀåÀº 2023³â 136¾ï 4,000¸¸ ´Þ·¯·Î ¿¹Ãø ±â°£ µ¿¾È 17.6%ÀÇ CAGR·Î ¼ºÀåÇØ 2030³â 424¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á¿ë ·Îº¿Àº º´¿ø ¹× ±âŸ ÀÇ·á ½Ã¼³¿¡¼ »ç¿ëµÇ´Â Àü¹® ¼ºñ½º ·Îº¿À¸·Î ȯÀÚ¿¡°Ô Á¦°øµÇ´Â Ä¡·áÀÇ ÁúÀ» Çâ»ó½Ãŵ´Ï´Ù. ¿Ü°ú ÀÇ»çÀÇ º¸´Ù Á¤È®Çϰí È¿°úÀûÀÎ ¼ö¼úÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ ÀÇ·áÁøÀÇ ¾÷¹« ºÎ´ãÀ» ÃÖ¼ÒÈÇϰí ȯÀÚ Ä¡·á¿¡ ´õ ¸¹Àº ½Ã°£À» ÇÒ¾ÖÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹ ¾ÈÀüÀ§¿øÈ¸(NSC)¿¡ µû¸£¸é, ¸Å³â ¾à 1,600¸¸ ¸í¿¡¼ 3,800¸¸ ¸íÀÇ ¿îµ¿¼±¼ö°¡ ½ÅüÀû ºÎ»óÀ» ÀԴ´ٰí ÇÕ´Ï´Ù.
¼ö¼ú¿ë ·Îº¿Àº Çö´ë ¿Ü°ú ¼ö¼úÀÇ »õ·Î¿î ¼ºÀå Æ÷ÀÎÆ®ÀÌÀÚ ±â¼ú ÀÎÅ¥º£ÀÌÅÍ·Î µîÀåÇß½À´Ï´Ù. ·Îº¿ º¸Á¶ ¼ö¼úÀº ÇöÀçÀÇ ÃÖ¼Ò Ä§½À ¼ö¼ú ±â¼úÀÇ ÇѰ踦 ±Øº¹Çϰųª ȯÀÚÀÇ °³º¹ ¼ö¼ú Áß ¿Ü°úÀÇ»çÀÇ ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇØ ¸¸µé¾îÁ³½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ »ç¿ëµÇ´Â ¼ö¼ú¿ë ·Îº¿Àº ÈäÅ͸¦ ÃÖ¼ÒÈÇϰí Ä¡À¯ ¼Óµµ¸¦ ³ôÀ̸ç ȸº¹ ½Ã°£À» ´ÜÃàÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÃÖ¼Ò Ä§½ÀÀû ¼ö¼ú Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ¼ö¼úÀ» º¸Á¶ÇÏ´Â ÀÇ·á¿ë ·Îº¿ÀÇ Àû¿ëÀ¸·Î ÀÎÇØ ¼ö¼úÀº ÀÌÁ¦ ÈξÀ ´õ È¿°úÀûÀ¸·Î ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. °á°úÀûÀ¸·Î ÀÌ·¯ÇÑ ¿äÀεéÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÇ·á¿ë ·Îº¿ ½ÃÀå¿¡¼ ³ôÀº Ãʱ⠺ñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¼ö¼ú¿ë ·Îº¿À̳ª ·Îº¿ º¸Á¶ ¼ö¼ú ½Ã½ºÅÛ°ú °°Àº ·Îº¿ Çϵå¿þ¾î´Â Ãʱ⠺ñ¿ëÀÌ ¸¸¸¸Ä¡ ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á¿ë ·Îº¿À» ÅëÇÕÇÏ·Á¸é Àü¿ë ¼ö¼ú½Ç°ú ÀÎÇÁ¶ó¸¦ ÀÚÁÖ º¯°æÇØ¾ß Çϱ⠶§¹®¿¡ Ãʱ⠺ñ¿ëÀÌ ´õ¿í ³ô¾ÆÁý´Ï´Ù. ±×·¯³ª ÀÇ·áÁøÀº ÀÇ·á¿ë ·Îº¿À» ¾ÈÀüÇÏ°Ô Á¶ÀÛÇÏ°í ½Ã¼úÀ» ¼öÇàÇϱâ À§ÇØ Àü¹®ÀûÀÎ ±³À°À» ¹Þ¾Æ¾ß ÇÕ´Ï´Ù.
·Îº¿ ½Ã½ºÅÛÀ» Ȱ¿ëÇÏ¸é ¾à¹°Àü´ÞÀÌ º¸´Ù Á¤È®Çϰí È¿À²ÀûÀ¸·Î ÀÌ·ç¾îÁú ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ·Îº¿Àº ¾à¹°À» Åõ¿©ÇÏ´Â ½Ã±â¿Í ¾çÀ» Á¤È®ÇÏ°Ô Á¶Á¤ÇÒ ¼ö ÀÖ¾î ¿øÇÏ´Â ºÎÀ§¿¡ ÀûÀýÇÑ ¾çÀÌ µµ´ÞÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ÀÌ´Â Á¤¸Æ ³» ¾à¹°Àü´ÞÀ̳ª ¾Ï Ä¡·á¿Í °°ÀÌ ¸Å¿ì ³ôÀº Á¤¹Ðµµ°¡ ¿ä±¸µÇ´Â ÀÇ·á ½Ã¼ú¿¡ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ¶ÇÇÑ, ·Îº¿ °øÇÐÀº Ç¥Àû ¾à¹°Àü´ÞÀ» ÃËÁøÇÒ ¼ö ÀÖÀ¸¸ç, °Ç°ÇÑ Á¶Á÷°ú ¼¼Æ÷¿¡ ´ëÇÑ ³ëÃâÀ» ÃÖ¼ÒÈÇÏ¸é¼ ¾à¹°À» ÇØ´ç ºÎÀ§ÀÇ Á¶Á÷°ú ¼¼Æ÷¿¡ ƯÀÌÀûÀ¸·Î À¯µµÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ºÎÀÛ¿ëÀ» ÁÙÀÌ¸é¼ Ä¡·á È¿°ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÇ·á¿ë ·Îº¿Àº Á¤±âÀûÀÎ ¼ö¸® ¹× Á¤±âÀûÀÎ À¯Áöº¸¼ö°¡ ÇÊ¿äÇÕ´Ï´Ù. °í°¡ÀÇ Áß´ÜÀ» ÇÇÇϱâ À§Çؼ´Â ±³Ã¼ ºÎǰÀÇ ¾ÈÁ¤ÀûÀÎ °ø±Þ°ú À¯Áöº¸¼ö¸¦ À§ÇÑ ¼÷·ÃµÈ ±â¼úÀÚ¸¦ È®º¸ÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÇ·á¿ë ·Îº¿Àº Áø´Ü, ¼ö¼ú µî ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹±âÄ¡ ¾ÊÀº ¿ÀÀÛµ¿À̳ª °íÀåÀÌ ¹ß»ýÇÏ¸é ¸¹Àº ´Ù¿îŸÀÓÀÌ ¹ß»ýÇÏ¿© ȯÀÚ Ä¡·á°¡ Áö¿¬µÇ°Å³ª ÀÇ·áÁø¿¡°Ô ºÒÆíÀ» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ·Îº¿ÀÇ °íÀåÀº ½Ç¼ö, ¹®Á¦, ¹Ù¶÷Á÷ÇÏÁö ¾ÊÀº °á°ú¸¦ ÃÊ·¡ÇÏ¿© ȯÀÚÀÇ ¾ÈÀüÀ» À§ÇùÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ À¯Áöº¸¼ö ¹× ¼ö¸®´Â ½ÃÀå ¼ö¿ä¿¡ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀº ÀÇ·á¿ë ·Îº¿ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. »ç¶÷°úÀÇ Á¢ÃËÀ» ÃÖ¼ÒÈÇØ¾ß ÇÏ´Â »óȲ¿¡¼ ÀÇ·á¿ë ·Îº¿¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ¿ø°ÝÁø·á¿Í ¿ø°ÝÀÇ·á°¡ ºü¸£°Ô È®»êµÇ¸é¼ ¿ø°ÝÁø·á ¹× ¼ö¼ú¿ë ·Îº¿ÀÌ °³¹ßµÇ¾î »çȸÀû °Å¸®µÎ±â¸¦ À¯ÁöÇÏ¸é¼ È¯ÀÚ Ä¡·á¸¦ ÃËÁøÇÏ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ UV-C ±¤¼± µîÀ» ÀÌ¿ëÇØ ÀÇ·á ȯ°æÀ» ¼Òµ¶ÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀÌ´Â ·Îº¿µµ µîÀåÇß½À´Ï´Ù. ÀÌ ½Ã±â¿¡ ¿¬±¸°³¹ßÀÌ °¡¼ÓÈµÇ¾î °Ëü äÃë, Áø´Ü, ¿ø°Ý ¸ð´ÏÅ͸µ¿ë ·Îº¿ µîÀÇ Çõ½ÅÀÌ Åº»ýÇß½À´Ï´Ù. ¶ÇÇÑ, COVID-19´Â ¸ðÀÇ ÈÆ·ÃÀ» ÅëÇØ ÀÇ·áÁøÀ» ÈÆ·Ã½ÃŰ´Â ÀÇ·á¿ë ·Îº¿ÀÇ ¿ªÇÒÀ» °Á¶Çϱ⵵ Çß½À´Ï´Ù.
º´¿ø°ú Ŭ¸®´Ð¿¡¼´Â ȯÀÚ°¡ ÇÑ ¹øÀÇ ¹æ¹®À¸·Î ¸ðµç Á¾·ùÀÇ Ä¡·á ¿É¼Ç°ú ÁøÂûÀ» ¹ÞÀ» ¼ö Àֱ⠶§¹®¿¡ º´¿ø ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È À¯¸®ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¬°£ º´¿ø ¼ö¿Í ¼ö¼ú °Ç¼ö´Â º´¿ø ¹× Ŭ¸®´ÐÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼ö¼ú, ÁÖÀÔ Áغñ, ¸ê±Õ, ¹°·ù, Áø´Ü µî ´Ù¾çÇÑ ÀÛ¾÷¿¡¼ ÀÇ·á¿ë ·Îº¿ÀÇ »ç¿ëÀÌ Áõ°¡ÇÏ¸é¼ º´¿ø ¹× Ŭ¸®´Ð ½ÃÀå ºÎ¹®¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
ºÏ¹Ì Áö¿ªÀº Á¤±³ÇÑ ÀÇ·á ÀÎÇÁ¶ó, °·ÂÇÑ R&D ¿ª·®, ¼ö¸¹Àº ÀÇ·á ±â°üÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Áö¿ªÀº ±â¼ú Çõ½ÅÀÇ Áß½ÉÁöÀ̸ç, ¸¹Àº À¯¸í ÀÇ·á¿ë ·Îº¿ Á¦Á¶¾÷ü, Çмú ±â°ü ¹× ÀÇ·á ½Ã¼³µéÀÌ Áö¼ÓÀûÀ¸·Î ¾÷°èÀÇ ÇѰ迡 µµÀüÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¿ø°Ý ÀÇ·á, ·Îº¿ º¸Á¶ ¼ö¼ú ¹× ÀçȰ ·Îº¿ÀÇ ±â¼ú Çõ½Å¿¡¼ ¼¼°è¸¦ ¼±µµÇϰí ÀÖÀ¸¸ç, ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
À¯·´Àº ¼±Áø±¹ÀÇ ³ëÀÎ Àα¸ Áõ°¡¿Í ÇコÄɾîÀÇ ¼¼°èÈ·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ¼öÀͼº ³ôÀº ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡´Â ¼ö¸¹Àº ÀÇ·á¿ë ·Îº¿ ¿¬±¸ ½Ã¼³°ú Çõ½Å Çãºê°¡ ÀÖ½À´Ï´Ù. ÀÌµé ¼¾ÅÍ´Â ÀÇ·á¿ë ·Îº¿ ±â¼ú °³¹ß ¹× ±¸ÇöÀÇ ÁøÀüÀ» ÃËÁøÇϱâ À§ÇØ Çаè»Ó¸¸ ¾Æ´Ï¶ó ¾÷°èÀÇ ÁÖ¿ä ±â¾÷µé°úµµ Çù·ÂÇϰí ÀÖ½À´Ï´Ù. À¯·´ ±¹°¡µéÀº ÀÇ·á ºÐ¾ß¿¡ ´ëÇÑ ÅõÀÚ¿¡ ´ëÇÑ °ÇÑ ÀÇÁö¸¦ Áö¼ÓÀûÀ¸·Î º¸¿©ÁÖ°í ÀÖÀ¸¸ç, ÀÌ Áö¿ªÀÇ ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ ÀçÁ¤Àû Áö¿øÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Medical Robotics Market is accounted for $13.64 billion in 2023 and is expected to reach $42.43 billion by 2030 growing at a CAGR of 17.6% during the forecast period. Medical robots are professional service robots used in hospitals and other healthcare facilities to improve the quality of care given to patients. It facilitates more precise and effective operations by surgeons. They create a substantial operational procedure that offers efficacy and low-cost investments in healthcare amenities while also minimizing the workload of medical staff, releasing them to spend more time directly caring for patients.
According to the National Safety Council (NSC), it was stated that about 1.6 to 3.8 million athletes get some sort of physical injury annually.
Surgical robotics has emerged as a new growth point and technological incubator in modern surgery. Robot-assisted surgeries were created to overcome the limitations of current minimally invasive surgery technologies or to enhance the abilities of surgeons during open surgery on a patient. Surgical robotics used in minimally invasive surgery helps to minimize scarring, speed up healing, and shorten recovery times. Surgical operations are now much more effective due to the growing demand for minimally invasive surgical treatments and the application of medical robotics to assist with surgical procedures. As a result, these factors are promoting market growth.
High initial costs serve as a notable restraint in the medical robotics market, hindering its growth. Robotic hardware, like surgical robots or robotic-assisted surgery systems, can have unaffordable initial costs. Moreover, the integration of medical robots frequently requires specialized operating rooms and infrastructural changes, which raises the initial costs even more. However, healthcare personnel must complete specialized training in order to safely operate medical robots and carry out procedures.
By leveraging robotic systems, drug delivery becomes more precise, targeted, and efficient. Medical robots are able to precisely regulate when and how much medication is administered, ensuring that the appropriate amount reaches the intended site. This is particularly helpful for medical procedures that require extreme precision, like intravenous drug delivery or cancer therapy. Additionally, robotics can facilitate targeted drug delivery, which minimizes exposure to healthy tissues and cells by directing medication specifically to affected tissues or cells. This method increases the therapeutic effect while lowering side effects. These factors propel market demand.
Medical robots need regular repairs as well as routine maintenance. To avoid expensive interruptions, it is crucial to guarantee a steady supply of replacement parts and skilled technicians for maintenance. Medical robots are essential to many aspects of healthcare, such as diagnosis and surgery. Any unforeseen malfunction or breakdown can cause a large amount of downtime, which could delay patient care and be inconvenient for medical staff. Medical robot malfunctions have a chance to put patient safety at risk by causing mistakes, problems, or unfavourable outcomes. Therefore, maintenance and repair is a significant barrier to market demand.
The COVID-19 pandemic significantly influenced the medical robotics market. With the need to minimize human-to-human contact, the demand for medical robots surged. Telemedicine and telehealth saw rapid adoption, leading to the development of robots for remote consultations and surgeries, facilitating patient care while maintaining social distancing. Robots were also deployed for disinfection, utilizing UV-C light and other methods to sanitize healthcare environments, reducing the risk of transmission. This period accelerated research and development, spawning innovations like robots for sample collection, diagnostics, and remote monitoring. The pandemic also emphasized the role of medical robots in training healthcare professionals through simulated procedures.
The laparoscopy segment is estimated to hold the largest share. Laparoscopic devices have proven to be effective tools for diagnostic and therapeutic purposes. Increases in funding and reimbursement policies have been noted for surgeries involving laparoscopies. Robot-assisted laparoscopy procedures have become increasingly common in recent years. Additionally, due to the numerous advantages of laparoscopic surgery, including small or no incision, brief hospital stays, less pain, short recovery times, fewer wounds, and decreased blood loss, there is a growing need for robot-assisted minimally invasive surgery.
The hospitals segment is anticipated to have lucrative growth during the forecast period, due to hospitals and clinics provide patients with all types of treatment options and consultations in a single visit. The number of hospitals and surgeries performed annually is driving the growth in hospitals and clinics. The increasing use of medical robotics for a range of tasks, such as surgery, IV preparations, sterilization, logistics, diagnostics, and more, contributes to the hospitals and clinics market segment.
North America commanded the largest market share during the extrapolated period due to its sophisticated healthcare infrastructure, strong capacity for research and development, and sizable number of healthcare institutions. The region is a center for technological innovation, with many well-known medical robot producers, academic institutions, and medical facilities constantly pushing the boundaries of the industry. North America leads the world in telemedicine, robotic-assisted surgery, and rehabilitation robot innovations, which drives market demand in this region.
Europe is expected to witness profitable growth over the projection period, due to the increasing geriatric population in developed countries and the globalization of healthcare. Numerous medical robotics research facilities and innovation hubs are located in Europe. To promote the advancement of medical robotic technology development and implementation, these centers work with influential individuals in the industry as well as academic institutions. European nations continue to show a strong commitment to investing in healthcare, giving financial support to healthcare facilities in this region.
Some of the key players in the Medical Robotics Market include: Titan Medical Inc., Renishaw Plc, Medrobotics Corporation, OR Productivity plc, Hansen, Mazor Robotics, iRobot Corporation, Intuitive Surgical, Health Robotics SLR, Mako Surgical Corp., Stereotaxis Inc., Accuray, Varian Medical Systems, Smith & Nephew, Zimmer Biomet, Medtronic and Stryker.
In Sept 2022 - Titan Medical entered into a limited development program agreement with Medtronic, whereby Medtronic will assess the effectiveness of Titan's instruments and cameras in gynecological procedures aligning with Titan Medical's plan to focus on gynecological procedures as the initial application for its surgical robot.
In Nov 2020, Medtronic (Ireland) acquired Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants.
In June 2020, Accuracy (US) launched the Cyber Knife S7 System a next-generation CyberKnife platform with advanced precision and real-time artificial intelligence (AI)-driven motion tracking and synchronization treatment delivery for all stereotactic radio surgery (SRS) and stereotactic body radiation therapy (SBRT) treatments.